| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TIPS.2013.03.004 |
| P698 | PubMed publication ID | 23582281 |
| P2093 | author name string | Natalia Novac | |
| P433 | issue | 5 | |
| P921 | main subject | drug repositioning | Q5308921 |
| P304 | page(s) | 267-272 | |
| P577 | publication date | 2013-04-12 | |
| P1433 | published in | Trends in Pharmacological Sciences | Q2451474 |
| P1476 | title | Challenges and opportunities of drug repositioning | |
| P478 | volume | 34 |
| Q24745976 | 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities |
| Q28552140 | A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases |
| Q26739665 | A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers |
| Q93163692 | A comparative chemogenic analysis for predicting Drug-Target Pair via Machine Learning Approaches |
| Q89704259 | A review of computational drug repurposing |
| Q90681544 | An Integrated System Biology Approach Yields Drug Repositioning Candidates for the Treatment of Heart Failure |
| Q39102210 | Application of Pharmacokinetics and Pharmacodynamics in Product Life Cycle Management. A Case Study with a Carbidopa-Levodopa Extended-Release Formulation. |
| Q48096762 | Better living through chemistry: Addressing emerging antibiotic resistance. |
| Q92723427 | CDK4/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation |
| Q50865512 | Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets. |
| Q89662547 | Computational approaches for drug discovery against trypanosomatid-caused diseases |
| Q35101970 | Computational drug repositioning through heterogeneous network clustering |
| Q58691544 | Deep Learning in Drug Discovery and Medicine; Scratching the Surface |
| Q36130167 | DenHunt - A Comprehensive Database of the Intricate Network of Dengue-Human Interactions |
| Q40094165 | Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses |
| Q39683991 | Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy |
| Q99709300 | Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak |
| Q64972663 | Drug Repurposing for Paracoccidioidomycosis Through a Computational Chemogenomics Framework. |
| Q36268794 | Drug-target interaction prediction via class imbalance-aware ensemble learning |
| Q28817678 | Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics |
| Q62743772 | Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine |
| Q92674148 | Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work |
| Q58762435 | Histone Deacetylase Inhibitors and Diabetic Kidney Disease |
| Q93054805 | Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms via Deep Convolutional Neural Network |
| Q50125592 | Inventing new therapies without reinventing the wheel: the power of drug repurposing. |
| Q92638270 | L2,1-GRMF: an improved graph regularized matrix factorization method to predict drug-target interactions |
| Q36097620 | Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective |
| Q38674008 | On the Integration of In Silico Drug Design Methods for Drug Repurposing |
| Q89792747 | On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients |
| Q44309573 | Opportunities for drug repositioning from phenome-wide association studies. |
| Q61448482 | Peptidyl-prolyl isomerase-B is involved in biofilm formation and a generic target for drug repurposing-based intervention |
| Q55501160 | Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity. |
| Q47133279 | Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration |
| Q90064867 | Predicting drug-induced transcriptome responses of a wide range of human cell lines by a novel tensor-train decomposition algorithm |
| Q64100901 | Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition |
| Q28534907 | Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity |
| Q31133470 | Prediction of new drug indications based on clinical data and network modularity |
| Q46484365 | Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications. |
| Q93202753 | Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein-ligand recognition process |
| Q57814810 | Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease |
| Q27011766 | Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis |
| Q55190915 | Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent. |
| Q41040260 | Repositioning of bromocriptine for treatment of acute myeloid leukemia |
| Q37159748 | Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay |
| Q66680196 | Repurposing of FDA-Approved NSAIDs for DPP-4 Inhibition as an Alternative for Diabetes Mellitus Treatment: Computational and in Vitro Study |
| Q90707908 | Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations |
| Q94589436 | Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19) |
| Q36932080 | The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis |
| Q60920319 | The computational prediction of drug-disease interactions using the dual-network L-CMF method |
| Q36268808 | The extraction of drug-disease correlations based on module distance in incomplete human interactome |
| Q107272762 | The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article |
| Q52670829 | The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug. |
| Q47268970 | Therapeutic drug repositioning using personalized proteomics of liquid biopsies. |
| Q33611069 | Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines |
| Q91727289 | Use of big data in drug development for precision medicine: an update |
| Q28818019 | Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases |
| Q30653282 | Vinpocetine inhibits Streptococcus pneumoniae-induced upregulation of mucin MUC5AC expression via induction of MKP-1 phosphatase in the pathogenesis of otitis media |
| Q35765498 | Warning letters to sponsor-investigators at academic health centres - the regulatory "canaries in a coal mine". |
Search more.